Zantac Breast Cancer Lawsuit Alleges Sanofi Failed To Warn Women Of The Risk

A Florida lawsuits claims that thousands of lives could have been saved had Sanofi Inc., not ignored the breast cancer-ranitidine connection

Thursday, December 9, 2021 - Breast cancer is a deadly life-threatening disease. Receiving a breast cancer diagnosis is a woman's most feared nightmare. Zantac ranitidine has been linked to causing breast cancer in numerous scientific studies, and at least two lawsuits that allege taking the anti-heartburn and acid reflux medicine caused them to develop the deadly disease. Online breast cancer organizations like BreastCancer.org and others are at the forefront of bringing the latest news about breast cancer to all who are interested. Hundreds of heartburn medicine cancer lawsuits allege that Zantac ranitidine causes stomach, bladder, esophagus, colon, and prostate cancer. One of the most distressing news reports in recent weeks is that taking Zantac heartburn and acid reflux medicine may also cause breast cancer. Lawsuits seek lump-sum monetary compensation from Sanofi, the maker of Zantac ranitidine, and link taking Zantac regularly for many years with causing the disease. Zantac lawyers are interviewing women that have been diagnosed with breast cancer and have taken the product who wish to file a claim.

Survivornet.com reports on a Florida woman who asserts that taking Zantac caused her breast cancer. The woman told reporters that she had taken Zantac regularly for about two decades for chronic heartburn and was then diagnosed with breast cancer. 44-year-old, former Boyton Beach, Florida school psychologist Jill Goldstein filed a lawsuit after receiving her breast cancer diagnosis, Ms. Goldstein researched the possible causes of breast cancer and discovered the ranitidine-cancer link. In an article published by Florida's Palm Beach Post, Ms. Goldstein's attorney cited a 2008 study that concluded a link between taking ranitidine and getting breast cancer specifically. "According to a 2008 study by a prestigious California-based cancer research institute, those who regularly take Zantac face a 240 percent greater risk of developing ductal carcinoma (breast cancer) than those who don't take the medication, Goldstein's attorneys said in a lawsuit filed late last month." For the mathematically challenged, that is about three and one-half times as likely to develop the disease. Women who have received a breast cancer diagnosis and have taken Zantac should contact a heartburn cancer lawyer to see if they qualify to file a claim. All women who have taken Zantac, whether or not they have been diagnosed with cancer may wish to join the class-action lawsuits seeking funding for ongoing breast cancer screening. The goal is to diagnose breast cancer in its earliest possible stage so that it may be treated effectively and extend life.

BreastCancer.org tells us that about one out of every 8, or an estimated 250,000 women in America will be diagnosed with breast cancer in her lifetime and that one out every thirty-nine women with breast cancer will die. The World Health Organization (WHO) tells us, "In 2020, there were 2.3 million women diagnosed with breast cancer worldwide, and 685 000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world's most prevalent cancer."

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.